Bridge City Capital’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.83M Buy
51,617
+16,108
+45% +$655K 0.51% 79
2025
Q4
$1.44M Sell
35,509
-6,794
-16% -$296K 0.42% 87
2025
Q3
$1.99M Sell
42,303
-727
-2% -$37.7K 0.53% 80
2025
Q2
$2.24M Sell
43,030
-612
-1% -$33.6K 0.63% 69
2025
Q1
$2.64M Sell
43,642
-414
-0.9% -$26.7K 0.79% 58
2024
Q4
$3.02M Buy
44,056
+7,597
+21% +$529K 0.8% 54
2024
Q3
$2.62M Buy
+36,459
New +$2.57M 0.72% 67

Other funds holding CNMD

Bridge City Capital's CNMD Position: Q1 2026 in Review

Bridge City Capital increased its CONMED (CNMD) stake by 45% in Q1 2026, buying an estimated $655K and bringing the position to 51,617 shares worth $1.83M. The position accounts for 0.51% of the portfolio, ranked #79.

Bridge City Capital first reported a position in CNMD in Q3 2024 and has held it in 7 quarters since. The position peaked at $3.02M in Q4 2024. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Bridge City Capital held 51,617 shares of CONMED worth $1.83M as of Q1 2026.
  • Bridge City Capital bought 16,108 CONMED shares in Q1 2026, an estimated $655K.
  • CONMED made up 0.51% of Bridge City Capital's portfolio in Q1 2026, its #79 holding.
  • Bridge City Capital first reported a position in CONMED in Q3 2024 and has held it in 7 quarters since.
  • Bridge City Capital's CONMED position peaked at $3.02M in Q4 2024.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Bridge City Capital's 13F filing for Q1 2026, filed 13 May 2026.